Literature DB >> 21482736

Plasmacytoid dendritic cells promote host defense against acute pneumovirus infection via the TLR7-MyD88-dependent signaling pathway.

Sophia Davidson1, Gerard Kaiko, Zhixuan Loh, Amit Lalwani, Vivian Zhang, Kirsten Spann, Shen Yun Foo, Nicole Hansbro, Satoshi Uematsu, Shizuo Akira, Klaus I Matthaei, Helene F Rosenberg, Paul S Foster, Simon Phipps.   

Abstract

Human respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infection in infants. In human infants, plasmacytoid dendritic cells (pDC) are recruited to the nasal compartment during infection and initiate host defense through the secretion of type I IFN, IL-12, and IL-6. However, RSV-infected pDC are refractory to TLR7-mediated activation. In this study, we used the rodent-specific pathogen, pneumonia virus of mice (PVM), to determine the contribution of pDC and TLR7 signaling to the development of the innate inflammatory and early adaptive immune response. In wild-type, but not TLR7- or MyD88-deficient mice, PVM inoculation led to a marked infiltration of pDC and increased expression of type I, II, and III IFNs. The delayed induction of IFNs in the absence of TLR7 or MyD88 was associated with a diminished innate inflammatory response and augmented virus recovery from lung tissue. In the absence of TLR7, PVM-specific CD8(+) T cell cytokine production was abrogated. The adoptive transfer of TLR7-sufficient, but not TLR7-deficient pDC to TLR7 gene-deleted mice recapitulated the antiviral responses observed in wild-type mice and promoted virus clearance. In summary, TLR7-mediated signaling by pDC is required for appropriate innate responses to acute pneumovirus infection. It is conceivable that as-yet-unidentified defects in the TLR7 signaling pathway may be associated with elevated levels of RSV-associated morbidity and mortality among otherwise healthy human infants.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21482736      PMCID: PMC3404606          DOI: 10.4049/jimmunol.1002635

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  60 in total

Review 1.  Respiratory syncytial virus and parainfluenza virus.

Authors:  C B Hall
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

2.  Cutting edge: differential chemokine production by myeloid and plasmacytoid dendritic cells.

Authors:  Giuseppe Penna; Marisa Vulcano; Andrea Roncari; Fabio Facchetti; Silvano Sozzani; Luciano Adorini
Journal:  J Immunol       Date:  2002-12-15       Impact factor: 5.422

3.  Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis.

Authors:  R P Garofalo; J Patti; K A Hintz; V Hill; P L Ogra; R C Welliver
Journal:  J Infect Dis       Date:  2001-07-13       Impact factor: 5.226

4.  Isolation and characterization of plasmacytoid dendritic cells from Flt3 ligand and granulocyte-macrophage colony-stimulating factor-treated mice.

Authors:  P Björck
Journal:  Blood       Date:  2001-12-15       Impact factor: 22.113

5.  Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus.

Authors:  E A Kurt-Jones; L Popova; L Kwinn; L M Haynes; L P Jones; R A Tripp; E E Walsh; M W Freeman; D T Golenbock; L J Anderson; R W Finberg
Journal:  Nat Immunol       Date:  2000-11       Impact factor: 25.606

6.  Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction.

Authors:  M Sato; H Suemori; N Hata; M Asagiri; K Ogasawara; K Nakao; T Nakaya; M Katsuki; S Noguchi; N Tanaka; T Taniguchi
Journal:  Immunity       Date:  2000-10       Impact factor: 31.745

7.  The chemokine macrophage-inflammatory protein-1 alpha and its receptor CCR1 control pulmonary inflammation and antiviral host defense in paramyxovirus infection.

Authors:  J B Domachowske; C A Bonville; J L Gao; P M Murphy; A J Easton; H F Rosenberg
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

8.  Type I interferons regulate inflammatory cell trafficking and macrophage inflammatory protein 1alpha delivery to the liver.

Authors:  Thais P Salazar-Mather; Casey A Lewis; Christine A Biron
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

9.  IFN-producing cells respond to CXCR3 ligands in the presence of CXCL12 and secrete inflammatory chemokines upon activation.

Authors:  Anne Krug; Ravindra Uppaluri; Fabio Facchetti; Brigitte G Dorner; Kathleen C F Sheehan; Robert D Schreiber; Marina Cella; Marco Colonna
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

10.  Virus-induced interferon alpha production by a dendritic cell subset in the absence of feedback signaling in vivo.

Authors:  Winfried Barchet; Marina Cella; Bernhard Odermatt; Carine Asselin-Paturel; Marco Colonna; Ulrich Kalinke
Journal:  J Exp Med       Date:  2002-02-18       Impact factor: 14.307

View more
  44 in total

Review 1.  TLR7/9 versus TLR3/MDA5 signaling during virus infections and diabetes.

Authors:  Melissa Swiecki; Stephen A McCartney; Yaming Wang; Marco Colonna
Journal:  J Leukoc Biol       Date:  2011-08-15       Impact factor: 4.962

Review 2.  dsRNA sensors and plasmacytoid dendritic cells in host defense and autoimmunity.

Authors:  Yaming Wang; Melissa Swiecki; Stephen A McCartney; Marco Colonna
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

3.  Genetic Architectures of Childhood- and Adult-Onset Asthma Are Partly Distinct.

Authors:  Manuel A R Ferreira; Riddhima Mathur; Judith M Vonk; Agnieszka Szwajda; Ben Brumpton; Raquel Granell; Bronwyn K Brew; Vilhelmina Ullemar; Yi Lu; Yunxuan Jiang; Patrik K E Magnusson; Robert Karlsson; David A Hinds; Lavinia Paternoster; Gerard H Koppelman; Catarina Almqvist
Journal:  Am J Hum Genet       Date:  2019-03-28       Impact factor: 11.025

4.  Microbiota regulates the TLR7 signaling pathway against respiratory tract influenza A virus infection.

Authors:  Sha Wu; Zhen-You Jiang; Yi-Fan Sun; Bin Yu; Jia Chen; Cong-Qi Dai; Xian-Lin Wu; Xiao-Long Tang; Xiao-Yin Chen
Journal:  Curr Microbiol       Date:  2013-05-16       Impact factor: 2.188

5.  Novel drugs targeting Toll-like receptors for antiviral therapy.

Authors:  Mira C Patel; Kari Ann Shirey; Lioubov M Pletneva; Marina S Boukhvalova; Alfredo Garzino-Demo; Stefanie N Vogel; Jorge Cg Blanco
Journal:  Future Virol       Date:  2014-09       Impact factor: 1.831

6.  Dual Role of Toll-Like Receptor 7 in the Pathogenesis of Rabies Virus in a Mouse Model.

Authors:  Zhaochen Luo; Lei Lv; Yingying Li; Baokun Sui; Qiong Wu; Yachun Zhang; Jie Pei; Mingming Li; Ming Zhou; D Craig Hooper; Zhen F Fu; Ling Zhao
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

Review 7.  The role of dendritic cells and monocytes in the maintenance and loss of respiratory tolerance.

Authors:  Cara L Hrusch; Melissa Y Tjota; Anne I Sperling
Journal:  Curr Allergy Asthma Rep       Date:  2015-01       Impact factor: 4.806

8.  Gene-based analysis of regulatory variants identifies 4 putative novel asthma risk genes related to nucleotide synthesis and signaling.

Authors:  Manuel A R Ferreira; Rick Jansen; Gonneke Willemsen; Brenda Penninx; Lisa M Bain; Cristina T Vicente; Joana A Revez; Melanie C Matheson; Jennie Hui; Joyce Y Tung; Svetlana Baltic; Peter Le Souëf; Grant W Montgomery; Nicholas G Martin; Colin F Robertson; Alan James; Philip J Thompson; Dorret I Boomsma; John L Hopper; David A Hinds; Rhiannon B Werder; Simon Phipps
Journal:  J Allergy Clin Immunol       Date:  2016-08-20       Impact factor: 10.793

9.  Human parainfluenza virus type 2 V protein inhibits TRAF6-mediated ubiquitination of IRF7 to prevent TLR7- and TLR9-dependent interferon induction.

Authors:  Yoshinori Kitagawa; Mayu Yamaguchi; Min Zhou; Machiko Nishio; Masae Itoh; Bin Gotoh
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

10.  Myd88-dependent toll-like receptor 7 signaling mediates protection from severe Ross River virus-induced disease in mice.

Authors:  Lauren M Neighbours; Kristin Long; Alan C Whitmore; Mark T Heise
Journal:  J Virol       Date:  2012-07-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.